2009 Annual Meeting | Non-Alzheimer's Dementia

Date Friday 05/01/09

Time 01:15 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Daniel Kaufer, MD, FAAN

Topic(s)

Learning Objectives Participants should beunderstand the differential diagnosis, clinical, laboratory, and neuroimaging evaluation, and comprehensive management of the main categories of non-AD dementia.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
01:15 PM - 02:00 PM		Parkinsonian Dementias Daniel Kaufer, MD, FAAN
02:00 PM - 02:45 PM		Metabolic, Infectious, and Other Dementias Douglas W. Scharre, MD, FAAN
02:45 PM - 03:00 PM		Break
03:00 PM - 03:45 PM		Vascular Cognitive Syndromes and Dementias Howard S. Kirshner, MD, FAAN
03:45 PM - 04:30 PM		Frontotemporal Dementias Bruce L. Miller, MD, FAAN
04:30 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Howard S. Kirshner, MD, FAAN	No disclosure on file
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Douglas W. Scharre, MD, FAAN	Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BrainTest, Inc. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Scharre has received research support from InSightec. The institution of Dr. Scharre has received research support from Alzheimer's Therapeutic Research Institute (ATRI). The institution of Dr. Scharre has received research support from Eisai. The institution of Dr. Scharre has received research support from vTv Therapeutics. The institution of Dr. Scharre has received research support from National Institute of Health. The institution of Dr. Scharre has received research support from Eli Lilly. The institution of Dr. Scharre has received research support from Biogen. The institution of Dr. Scharre has received research support from Roche. The institution of Dr. Scharre has received research support from Percision Medicine. The institution of Dr. Scharre has received research support from Premier Research Group. The institution of Dr. Scharre has received research support from Genetch. The institution of Dr. Scharre has received research support from Avanir. The institution of Dr. Scharre has received research support from Cerevel Therapeutics. The institution of Dr. Scharre has received research support from Janssen. The institution of Dr. Scharre has received research support from Cassava. The institution of Dr. Scharre has received research support from UniQure. The institution of Dr. Scharre has received research support from Cognition Therapeutics. The institution of Dr. Scharre has received research support from Cognitive Research Corporation. The institution of Dr. Scharre has received research support from EIP. The institution of Dr. Scharre has received research support from Cognito. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care.
Daniel Kaufer, MD, FAAN	No disclosure on file

��ɫ��

��ɫ��